October 1, 2021 2:34 pm
Published by Fluidda
In a recent publication in CHEST Journal, the importance of the small airways and their contribution to symptoms of asthma and COPD are discussed. Significant small airways dysfunction can be found... View Article
July 9, 2021 3:20 pm
Published by Fluidda
A well powered study with FRI as primary endpoint shows the potential of an inhaled P13K delta inhibitor in COPD-exacerbations. A recent paper, published in the Int. Journal of Chronic Obstructive... View Article
February 23, 2021 10:55 am
Published by Fluidda
In a recent study by Usmani et al. , FRI was used to evaluate lung deposition of extrafine beclomethasone dipropionate (BDP)/formoterol fumarate (FF)/glycopyrronium bromide (GB) and extrafine BDP/FF delivered through pressurized metered... View Article
November 27, 2020 11:26 am
Published by Fluidda
Evaluations of inhaler use have demonstrated that mishandling of pMDIs (Pressurized Meter Dose Inhalers) is commonplace. One of the most common errors is the failure to coordinate inhalation with actuation... View Article
November 18, 2020 9:31 am
Published by Fluidda
The use of Fluidda’s FRI technology in the combat against COPD. The exact prevalence of COPD worldwide is largely unknown, but estimates have varied from 7-19%. The Burden of Obstructive Lung Disease (BOLD) study... View Article
September 11, 2020 11:00 am
Published by Fluidda
Functional Respiratory Imaging (FRI) shows significant regional ventilation defects in COPD patients as compared to healthy patients Ventilation defects in COPD are associated with reduced exercise tolerance and worse quality... View Article
September 9, 2020 11:32 am
Published by Fluidda
Ventilation-perfusion measures based on FRI correlates with exercise tolerance in COPD COPD affects the lungs in many ways. A common problem is reduced ventilation-perfusion (V/Q) values caused by airway disease... View Article
May 19, 2020 11:23 am
Published by Fluidda
New published article: FRI assessment of glycopyrrolate and formoterol fumarate pMDI formulations using co-suspension delivery technology in COPD. Understanding lungs and lung diseases has never been more important than in... View Article
October 24, 2019 4:31 pm
Published by Fluidda
Mucus plays a major role in Chronic Obstructive Pulmonary Disease (COPD), especially in the Chronic Bronchitis phenotypes. Mucus increases airway resistance making it harder for the patient to breath. At... View Article
September 16, 2018 12:44 pm
Published by Fluidda webmaster
Van Geffen et al.
International Journal of COPD 2018:13 1783–1792